Supplementary Table S2 from Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children’s Oncology Group

Florette K. Hazard; Angus M.S. Toland; Serena Y. Tan; Bill Chiu; Naohiko Ikegaki; Arlene H. Naranjo; Susan Lerner Cohn; Wendy B. London; Julie M. Gastier‐Foster; Nilsa C. Ramirez; Shalini C. Reshmi; Elizabeth Wagner; Jed G. Nuchtern; Shahab Asgharzadeh; Araz Marachelian; John M. Maris; Rochelle Bagatell; Julie R. Park; Meredith S. Irwin; Michael D. Hogarty; Hiroyuki Shimada

doi:10.1158/1078-0432.31006687

Supplementary Table S2 from Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children’s Oncology Group

2026 Open access

Read full text

Authors: Florette K. Hazard, Angus M.S. Toland, Serena Y. Tan, Bill Chiu, Naohiko Ikegaki, Arlene H. Naranjo, Susan Lerner Cohn, Wendy B. London, Julie M. Gastier‐Foster, Nilsa C. Ramirez, Shalini C. Reshmi, Elizabeth Wagner

+9 more

Jed G. Nuchtern, Shahab Asgharzadeh, Araz Marachelian, John M. Maris, Rochelle Bagatell, Julie R. Park, Meredith S. Irwin, Michael D. Hogarty, Hiroyuki Shimada

DOI: 10.1158/1078-0432.31006687

Cited by: 0

Fields of Study & Subjects

Neuroblastoma Research and Treatments Lung Cancer Research Studies Neuroendocrine Tumor Research Advances

Publication details

Publication date: 6 January 2026